Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 18.76B INR in the quarter ending December 31, 2025, with 10.84% growth. This brings the company's revenue in the last twelve months to 72.67B, up 13.20% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

• Revenue (ttm): 72.67B
• Revenue Growth: +13.20%
• P/S Ratio: 2.10
• Revenue / Employee: 4.39M
• Employees: 16,571
• Market Cap: 152.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	66.72B	4.43B	7.12%
Mar 31, 2024	62.29B	5.76B	10.19%
Mar 31, 2023	56.53B	3.47B	6.54%
Mar 31, 2022	53.06B	-873.40M	-1.62%
Mar 31, 2021	53.93B	7.87B	17.10%